VAN VOORHEES SETH (Chief Financial Officer) purchased 183.6% of their position (30K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $33.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/19/2022ACC: 0001415889-22-012652
Officer· Chief Financial Officer
Since Jun 2022
+30K
Net shares
Net buyer
$33.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Direct
Shares
+30K
Price / share
$1.10
Trade value
$33K
% of position
183.6%
12/16/2022
16.34K→46.34K
Total
Net shares
+30K
Net value
$33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 12/16/2022 | P · Purchase | +30K | $1.10 | $33K | 183.6% | 16.34K | 46.34K |
| Total | +30K | $33K | ||||||
Derivative Transactions0
No derivative transactions reported